High levels of wilms' tumor 1 (WT1) expression were associated with aggressive clinical features in ovarian cancer

Zhiyang Liu, Keiko Yamanouchi, Tsuyoshi Ohtao, Sohei Matsumura, Manabu Seino, Vijayalakshmi Shridhar, Toshifumi Takahashi, Kazuhiro Takahashi, Hirohisa Kurachi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Aim: The aim of the present study was to evaluate the correlation between WT1 expression levels and clinical features, to investigate the prognostic value of WT1 expression and to use lentiviral constructs to examine whether overexpression of WT1 affects cell proliferation and invasion in ovarian cancer patients. Materials and Methods: Real-time quantitative PCR (qPCR) methods were employed to analyze WT1 expression levels in clinical samples from 63 patients with ovarian cancer. The correlation between the copy number of WT1 mRNA and clinical variables was analyzed. Results: The median copy number of WT1 mRNA was 53.94 (range=2.135-32,257) in all subjects and WT1 expression levels were found significantly increased in patients with a higher stage cancer (p<0.05), lymphnode (p<0.001) and omentum metastasis (p<0.001), as well as ascites production (p<0.05), compared to patients lacking these clinical variables. No significant difference in WT1 expression levels were observed between patients with and without recurrence. The median disease-free survival time in patients with low WT1 expression levels was significantly longer (p=0.038) than that in patients with high WT1 expression. However, overall survival curves showed no statistically significant (p=0.457) differences between patients with high-And low-WT1 expression levels. An in vitro study revealed that WT1 over-expression enhanced cell proliferation and invasion in ovarian cancer cells transduced with lentiviral constructs. Conclusion: Using qPCR, we found that high levels of WT1 expression correlated with aggressive clinical features in ovarian cancer. High WT1 expression may impact on median disease-free survival in ovarian cancer.

Original languageEnglish (US)
Pages (from-to)2331-2340
Number of pages10
JournalAnticancer Research
Volume34
Issue number5
StatePublished - May 1 2014

Fingerprint

Wilms Tumor
Ovarian Neoplasms
Disease-Free Survival
Cell Proliferation
Messenger RNA
Omentum
Ascites
Real-Time Polymerase Chain Reaction

Keywords

  • Clinical features
  • Disease-free survival
  • Lentivirus
  • Ovarian cancer
  • Overall survival
  • Prognosis
  • Real-time quantitative PCR
  • WT1

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Liu, Z., Yamanouchi, K., Ohtao, T., Matsumura, S., Seino, M., Shridhar, V., ... Kurachi, H. (2014). High levels of wilms' tumor 1 (WT1) expression were associated with aggressive clinical features in ovarian cancer. Anticancer Research, 34(5), 2331-2340.

High levels of wilms' tumor 1 (WT1) expression were associated with aggressive clinical features in ovarian cancer. / Liu, Zhiyang; Yamanouchi, Keiko; Ohtao, Tsuyoshi; Matsumura, Sohei; Seino, Manabu; Shridhar, Vijayalakshmi; Takahashi, Toshifumi; Takahashi, Kazuhiro; Kurachi, Hirohisa.

In: Anticancer Research, Vol. 34, No. 5, 01.05.2014, p. 2331-2340.

Research output: Contribution to journalArticle

Liu, Z, Yamanouchi, K, Ohtao, T, Matsumura, S, Seino, M, Shridhar, V, Takahashi, T, Takahashi, K & Kurachi, H 2014, 'High levels of wilms' tumor 1 (WT1) expression were associated with aggressive clinical features in ovarian cancer', Anticancer Research, vol. 34, no. 5, pp. 2331-2340.
Liu, Zhiyang ; Yamanouchi, Keiko ; Ohtao, Tsuyoshi ; Matsumura, Sohei ; Seino, Manabu ; Shridhar, Vijayalakshmi ; Takahashi, Toshifumi ; Takahashi, Kazuhiro ; Kurachi, Hirohisa. / High levels of wilms' tumor 1 (WT1) expression were associated with aggressive clinical features in ovarian cancer. In: Anticancer Research. 2014 ; Vol. 34, No. 5. pp. 2331-2340.
@article{9dcffa32766a484bb394ee760a78ccad,
title = "High levels of wilms' tumor 1 (WT1) expression were associated with aggressive clinical features in ovarian cancer",
abstract = "Aim: The aim of the present study was to evaluate the correlation between WT1 expression levels and clinical features, to investigate the prognostic value of WT1 expression and to use lentiviral constructs to examine whether overexpression of WT1 affects cell proliferation and invasion in ovarian cancer patients. Materials and Methods: Real-time quantitative PCR (qPCR) methods were employed to analyze WT1 expression levels in clinical samples from 63 patients with ovarian cancer. The correlation between the copy number of WT1 mRNA and clinical variables was analyzed. Results: The median copy number of WT1 mRNA was 53.94 (range=2.135-32,257) in all subjects and WT1 expression levels were found significantly increased in patients with a higher stage cancer (p<0.05), lymphnode (p<0.001) and omentum metastasis (p<0.001), as well as ascites production (p<0.05), compared to patients lacking these clinical variables. No significant difference in WT1 expression levels were observed between patients with and without recurrence. The median disease-free survival time in patients with low WT1 expression levels was significantly longer (p=0.038) than that in patients with high WT1 expression. However, overall survival curves showed no statistically significant (p=0.457) differences between patients with high-And low-WT1 expression levels. An in vitro study revealed that WT1 over-expression enhanced cell proliferation and invasion in ovarian cancer cells transduced with lentiviral constructs. Conclusion: Using qPCR, we found that high levels of WT1 expression correlated with aggressive clinical features in ovarian cancer. High WT1 expression may impact on median disease-free survival in ovarian cancer.",
keywords = "Clinical features, Disease-free survival, Lentivirus, Ovarian cancer, Overall survival, Prognosis, Real-time quantitative PCR, WT1",
author = "Zhiyang Liu and Keiko Yamanouchi and Tsuyoshi Ohtao and Sohei Matsumura and Manabu Seino and Vijayalakshmi Shridhar and Toshifumi Takahashi and Kazuhiro Takahashi and Hirohisa Kurachi",
year = "2014",
month = "5",
day = "1",
language = "English (US)",
volume = "34",
pages = "2331--2340",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5",

}

TY - JOUR

T1 - High levels of wilms' tumor 1 (WT1) expression were associated with aggressive clinical features in ovarian cancer

AU - Liu, Zhiyang

AU - Yamanouchi, Keiko

AU - Ohtao, Tsuyoshi

AU - Matsumura, Sohei

AU - Seino, Manabu

AU - Shridhar, Vijayalakshmi

AU - Takahashi, Toshifumi

AU - Takahashi, Kazuhiro

AU - Kurachi, Hirohisa

PY - 2014/5/1

Y1 - 2014/5/1

N2 - Aim: The aim of the present study was to evaluate the correlation between WT1 expression levels and clinical features, to investigate the prognostic value of WT1 expression and to use lentiviral constructs to examine whether overexpression of WT1 affects cell proliferation and invasion in ovarian cancer patients. Materials and Methods: Real-time quantitative PCR (qPCR) methods were employed to analyze WT1 expression levels in clinical samples from 63 patients with ovarian cancer. The correlation between the copy number of WT1 mRNA and clinical variables was analyzed. Results: The median copy number of WT1 mRNA was 53.94 (range=2.135-32,257) in all subjects and WT1 expression levels were found significantly increased in patients with a higher stage cancer (p<0.05), lymphnode (p<0.001) and omentum metastasis (p<0.001), as well as ascites production (p<0.05), compared to patients lacking these clinical variables. No significant difference in WT1 expression levels were observed between patients with and without recurrence. The median disease-free survival time in patients with low WT1 expression levels was significantly longer (p=0.038) than that in patients with high WT1 expression. However, overall survival curves showed no statistically significant (p=0.457) differences between patients with high-And low-WT1 expression levels. An in vitro study revealed that WT1 over-expression enhanced cell proliferation and invasion in ovarian cancer cells transduced with lentiviral constructs. Conclusion: Using qPCR, we found that high levels of WT1 expression correlated with aggressive clinical features in ovarian cancer. High WT1 expression may impact on median disease-free survival in ovarian cancer.

AB - Aim: The aim of the present study was to evaluate the correlation between WT1 expression levels and clinical features, to investigate the prognostic value of WT1 expression and to use lentiviral constructs to examine whether overexpression of WT1 affects cell proliferation and invasion in ovarian cancer patients. Materials and Methods: Real-time quantitative PCR (qPCR) methods were employed to analyze WT1 expression levels in clinical samples from 63 patients with ovarian cancer. The correlation between the copy number of WT1 mRNA and clinical variables was analyzed. Results: The median copy number of WT1 mRNA was 53.94 (range=2.135-32,257) in all subjects and WT1 expression levels were found significantly increased in patients with a higher stage cancer (p<0.05), lymphnode (p<0.001) and omentum metastasis (p<0.001), as well as ascites production (p<0.05), compared to patients lacking these clinical variables. No significant difference in WT1 expression levels were observed between patients with and without recurrence. The median disease-free survival time in patients with low WT1 expression levels was significantly longer (p=0.038) than that in patients with high WT1 expression. However, overall survival curves showed no statistically significant (p=0.457) differences between patients with high-And low-WT1 expression levels. An in vitro study revealed that WT1 over-expression enhanced cell proliferation and invasion in ovarian cancer cells transduced with lentiviral constructs. Conclusion: Using qPCR, we found that high levels of WT1 expression correlated with aggressive clinical features in ovarian cancer. High WT1 expression may impact on median disease-free survival in ovarian cancer.

KW - Clinical features

KW - Disease-free survival

KW - Lentivirus

KW - Ovarian cancer

KW - Overall survival

KW - Prognosis

KW - Real-time quantitative PCR

KW - WT1

UR - http://www.scopus.com/inward/record.url?scp=84902954932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902954932&partnerID=8YFLogxK

M3 - Article

C2 - 24778040

AN - SCOPUS:84902954932

VL - 34

SP - 2331

EP - 2340

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5

ER -